Shanghai Pioneer Holding Ltd (HKG:1345)

Market Cap	2.60B
Revenue (ttm)	1.63B
Net Income (ttm)	161.35M
Shares Out	1.16B
EPS (ttm)	0.14
PE Ratio	16.09
Forward PE	n/a
Dividend	0.11 (4.95%)
Ex-Dividend Date	Jun 3, 2025

Volume	118,000
Average Volume	105,550
Open	2.200
Previous Close	2.230
Day's Range	2.150 - 2.260
52-Week Range	1.700 - 2.450
Beta	0.29
RSI	51.73
Earnings Date	Mar 26, 2025

About Shanghai Pioneer Holding

Shanghai Pioneer Holding Ltd, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People’s Republic of China. The company offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas. It also sells medical devices, including ophthalmology, orthopedics, odontology, and wound care products. In addition, the company engages in sale of ancillary tools, dental devices, and imported in-licens...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1996
• Employees: 335
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1345

Financial Performance

In 2024, Shanghai Pioneer Holding's revenue was 1.53 billion, a decrease of -2.27% compared to the previous year's 1.57 billion. Earnings were 151.62 million, an increase of 4.05%.

Financial numbers in CNY